Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOptiBiotix Health Regulatory News (OPTI)

Share Price Information for OptiBiotix Health (OPTI)

Share Price is delayed by 15 minutes
Get Live Data
6.25    0.00 (0.00%)
Bid:
6.00
Ask:
6.50
Spread: 0.50 (8.333%)
Market Cap: £6.46m
OPTI Live PriceLast checked at - London Stock Exchange

Intraday OptiBiotix Health Share Chart

Holding(s) in Company

25 Mar 2015 12:54

RNS Number : 4483I
OptiBiotix Health PLC
25 March 2015
 

 

TR-1: NOTIFICATIONS OF MAJOR INTERESTS IN SHARESi

 

 

1. Identity of the issuer or the underlying issuerof existing shares to which voting rights areattached: ii

OptiBiotix Health Plc

 

2 Reason for the notification (please tick the appropriate box or boxes):

An acquisition or disposal of voting rights

ü

An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached

 

An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments

 

An event changing the breakdown of voting rights

 

Other (please specify):

 

 

3. Full name of person(s) subject to thenotification obligation: iii

Helium Rising Stars Fund

4. Full name of shareholder(s) (if different from 3.):iv

 

5. Date of the transaction and date onwhich the threshold is crossed orreached: v

 

24/03/2015

 

6. Date on which issuer notified:

 

25/03/2015

 

7. Threshold(s) that is/are crossed orreached: vi, vii

9%

     

 

8. Notified details:

A: Voting rights attached to shares viii, ix

Class/type ofshares

if possible usingthe ISIN CODE

Situation previousto the triggeringtransaction

Resulting situation after the triggering transaction

NumberofShares

NumberofVotingRights

Numberof shares

Number of votingrights

% of voting rights x

Direct

Direct xi

Indirect xii

Direct

Indirect

 

GB00BPORTP38

7,125,000

7,125,000

6,225,000

6,225,000

-

8.59%

 

 

 

B: Qualifying Financial Instruments

Resulting situation after the triggering transaction

Type of financialinstrument

Expirationdate xiii

Exercise/Conversion Period xiv

Number of votingrights that may beacquired if theinstrument isexercised/ converted.

% of votingrights

 

 

 

 

 

 

C: Financial Instruments with similar economic effect to Qualifying Financial Instruments xv, xvi

Resulting situation after the triggering transaction

Type of financialinstrument

Exercise price

Expiration date xvii

Exercise/Conversion period xviii

Number of voting rights instrument refers to

 

% of voting rights xix, xx

 

 

 

 

 

 

 

Nominal

Delta

 

 

 

Total (A+B+C)

Number of voting rights

Percentage of voting rights

6,225,000

8.59%

                 

 

9. Chain of controlled undertakings through which the voting rights and/or thefinancial instruments are effectively held, if applicable: xxi

 

 

 

Proxy Voting:

10. Name of the proxy holder:

 

11. Number of voting rights proxy holder will ceaseto hold:

 

12. Date on which proxy holder will cease to holdvoting rights:

 

 

13. Additional information:

 

14. Contact name:

Dimitrij Nabatov, ISPartners (Co-Advisor to the Helium Rising Stars Fund)

15. Contact telephone number:

 

+41 43 888 7343

   

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
HOLPGUWAWUPAGPA
Date   Source Headline
2nd Jun 20267:00 amRNS-RInvestor presentation and SweetBiotix® Sampling
29th May 20267:00 amRNSDirector/PDMR Shareholding
28th May 20267:00 amRNSFinal Results & Notice of AGM
14th May 20267:00 amRNS-RSweetBiotix® Sampling
5th May 20262:30 pmRNSHolding(s) in Company
1st May 202612:00 pmRNSPartial Disposal of Shares in SkinBioTherapeutics
1st Apr 20267:00 amRNSTrading Update
24th Feb 20267:00 amRNSWellBiome® clinical trial on surgical outcomes
17th Feb 20267:00 amRNSStatement: SkinBioTherapeutics Announcement
21st Jan 20267:00 amRNSLarge Order and Record Early Orders for 2026
20th Jan 20267:00 amRNS-RNew Investor Website
2nd Jan 20267:00 amRNSHolding(s) in Company
2nd Jan 20267:00 amRNSHolding(s) in Company
24th Nov 20257:00 amRNSSweetBiotix Overview and Update
17th Nov 20257:00 amRNSOrder with well-known Weight Management Company
13th Oct 20253:31 pmRNSHolding(s) in Company
2nd Oct 20257:00 amRNSDirector/PDMR Shareholding
24th Sep 202512:28 pmRNSDirector/PDMR Shareholding
16th Sep 20257:00 amRNSHalf-year Report
21st Aug 20257:00 amRNSAdmission to Trading on the OTCQB Venture Market
20th Aug 20257:00 amRNSAgreement with Weight Management Company
14th Aug 20257:00 amRNSLaunch of SlimBiome in leading US brand
6th Aug 20254:08 pmRNSResult of AGM
6th Aug 20257:00 amRNSIssue of Options
28th Jul 20257:00 amRNSTrading update
30th Jun 20257:00 amRNSChange of Broker
30th Jun 20257:00 amRNSFinal Results
11th Jun 20257:00 amRNS-RSlimBiome® study in European Journal of Nutrition
23rd May 20257:00 amRNSPlacing and Issue of Warrants
20th May 20257:00 amRNSLaunch of SlimBiome products with US partner
15th Apr 20257:00 amRNSFirst order from US weight management brand
7th Apr 20255:34 pmRNSHolding(s) in Company
18th Mar 20257:00 amRNSCommercial Update
18th Feb 20257:00 amRNSLaunch of Daily Nouri FeelFull product in America
20th Jan 20257:00 amRNS-RLaunch of products on Amazon India
8th Jan 20257:00 amRNSDirectorate Change
20th Dec 202412:00 pmRNSIssue of Options
12th Dec 20242:45 pmRNSHolding(s) in Company
3rd Dec 20247:00 amRNSLaunch of Dr Morepen LightLife in India
30th Oct 20247:00 amRNSRequisition update
25th Oct 20244:29 pmRNSHolding(s) in Company
24th Oct 20247:00 amRNSTotal Voting Rights
23rd Oct 20247:00 amRNSDirectorate Change
18th Oct 20247:00 amRNSResponse to Publication of Circular by ProBiotix
10th Oct 20247:00 amRNSSlimBiome study update
27th Sep 20247:00 amRNSHalf-year Report
26th Sep 20247:00 amRNSResponse to Probiotix Health requisition notice
5th Sep 202410:32 amRNSProBiotix Health plc Fundraise
20th Aug 20247:00 amRNSCommercial update
8th Aug 202412:29 pmRNSResult of AGM

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.